-
-
7 . Academic Journal
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials
- 저자
- by Cole, Abosede O; Gerstenblith, Adam T; Kotagiri, Ajay; Edwards, Albert O; Zambrano, Alberto D, et al.
- 소스
- In The Lancet 21-27 October 2023 402(10411):1434-1448
-
-
7 . Academic Journal
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials
- 저자
- by Aaberg, Thomas, Jr; Abbey, Ashkan; Abdulaeva, Elmira; Abengoechea, Santiago; Abraham, Prema, et al.
- 소스
- In The Lancet 19-25 February 2022 399(10326):741-755
-
7 . Periodical
Pegcetacoplan for the treatment of geographic atrophy secondary to age-related macular degeneration (OAKS and DERBY): two multicentre, randomised, double-masked, sham-controlled, phase 3 trials
- 저자
- by Heier, Jeffrey S; Lad, Eleonora M; Holz, Frank G; Rosenfeld, Philip J; Guymer, Robyn H, et al.
- 소스
- The Lancet; October 2023, Vol. 402 Issue: 10411 p1434-1448, 15p
-
7 . Periodical
Efficacy, durability, and safety of intravitreal faricimab with extended dosing up to every 16 weeks in patients with diabetic macular oedema (YOSEMITE and RHINE): two randomised, double-masked, phase 3 trials
- 저자
- by Wykoff, Charles C; Abreu, Francis; Adamis, Anthony P; Basu, Karen; Eichenbaum, David A, et al.
- 소스
- The Lancet; February 2022, Vol. 399 Issue: 10326 p741-755, 15p
-